Streetwise Company Fact Sheet2025/4/3 15:15:50
(SVA:TSX.V - SEOVF:OTCQB - PSH:XETRA)
Analyst coverage
| Rodman & Renshaw — Dr. Tony Butler |
| Raymond James — Michael Freeman |
| Leede Financial Inc. — Dr. Douglas Loe |
| Leede Jones Gable — Doug Loe |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
| Echelon Capital Markets — Stefan Quenneville |
| Raymond James — Rahul Sarugaser |
| Research Capital Corporation — Dr. Andre Uddin |
Newsletter coverage
| — |
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 04/03/2025 - View Article |
| 04/03/2025 - View Article |
| 03/10/2025 - View Article |
| 03/06/2025 - View Article |
| 02/06/2025 - View Article |
Streetwise - Sernova Biotherapeutics Inc. Ownership Overview*
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA)
Company News
4/1/2025 – Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch(TM) Bio-Hybrid Organ for Treatment of Type 1 Diabetes
3/3/2025 – Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
2/3/2025 – Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
